UNSPSC 51281647: Framycetin sulfate

This classification denotes an aminoglycoside antibiotic with the molecular formula C23H46N6O13.3H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y3720KZ4TQ, chemically known as neomycin b, sulfate (salt) but more generally known as framycetin sulfate, which bears US NIH Compound Identifier 197162. European Medicines Agency schedules Framycetin sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02269MIG.

UNSPSC 51281647 Framycetin sulfate is a Commodity code that describes a specific antibiotic pharmaceutical product, yet the recent state and local opportunities posted under this code do not reflect procurement of framycetin sulfate itself. Instead, the opportunities tagged to this code show state and local health agencies sourcing unrelated pharmaceutical products and medical supplies—including antibiotic tablets, naloxone, and drug deactivation systems—through piggyback contracts and competitive bidding. This mismatch between the code's nominal scope and the actual solicitations suggests the code sees limited relevant activity, or that issuing bodies are applying the code incorrectly to broader pharmaceutical procurement categories.

The two most recent records show Illinois Department of Public Health awarding a completed piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC for doxycycline hyclate and ciprofloxacin hydrochloride tablets (Solicitation 26482DPHPREPDB53392, award August 28, 2026, $2,999,999.11 over three years), and Seminole County, Florida issuing an IFB for naloxone and drug deactivation systems (Solicitation IFB60459723LAS, due July 26, 2023, 1,900 units of naloxone and 800 deactivation systems annually). Neither opportunity involves framycetin sulfate procurement. The issuing bodies are a state health department and a county government; activity appears concentrated in the Southeast and Midwest, though the limited record set does not support a broad geographic characterization. Business development professionals should verify whether opportunities are correctly tagged to this code or whether framycetin sulfate demand exists under different classification.